Using immunological methods to determine human serum METCAM/MUC18 concentration for prediction of the possible malignant potential of prostate cancer.
碩士 === 中原大學 === 化學工程研究所 === 103 === Prostate cancer in 10% of prostate cancer patients are aggressive and metastatic, killing the patients within one year of the initial diagnosis. The current dominant diagnosis for the cancer is to test an elevated serum PSA level. However the diagnosis test has at...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2015
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/6bq3h5 |